Suraksha Diagnostic Results Update
Suraksha Diagnostic reported FY26 total income of ₹313.58 Crore, up 22.5% year-on-year. EBITDA reached ₹98.56 Crore as the company expanded its regional diagnostic footprint.
- Value
- ₹313.6 Cr
ALFA Filings
Every announcement, straight from the exchange
Every corporate announcement our alert engine sent, newest first: orders, results, earnings calls, fund raises, board meetings and more.
Announcement type
Time
122,865 announcements
Suraksha Diagnostic reported FY26 total income of ₹313.58 Crore, up 22.5% year-on-year. EBITDA reached ₹98.56 Crore as the company expanded its regional diagnostic footprint.
Bajaj Electricals allotted 2,056 equity shares following the exercise of employee stock options. This routine issuance slightly increases the company's total paid-up share capital.
Hubtown Limited hosted its Q4 FY26 analyst meet in Mumbai, discussing its 11,300 crore unrecognized revenue pipeline and ongoing luxury project mergers.
Gem Aromatics reports sequential recovery in Q4FY26 with revenue of ₹110 Cr (Consolidated). Focus is on ramp-up at the greenfield Dahej facility and higher-value specialty molecules.
Ramco Systems posted FY26 revenue of USD 79.9m, representing 13% YoY growth. Annual EBITDA stood at USD 18.9m, reflecting improved operational efficiency and recurring revenue growth.
Aurobindo Pharma appointed M/s. RPR & Associates as Secretarial Auditor for five years following M/s. MRR & Associates' resignation. The transition is due to proprietor health issues.
K K Silk Mills Ltd scheduled a board meeting for May 29, 2026. Directors will consider and approve audited financial results for fiscal year 2026.
India Glycols' NCLT hearing for its Scheme of Arrangement was deferred due to paucity of time. A new hearing date is yet to be notified.
Manali Petrochemicals reported a consolidated annual income of ₹1069.85 Crore. The Board recommended a ₹0.50 per share dividend, reflecting steady performance across overseas subsidiaries.
Allcargo Terminals delivered a strong FY26 with 46% PAT growth and 26% EBITDA growth, driven by record volumes and capacity expansion at JNPT.
Ramco Systems Ltd reported revenue from operations of ₹185.4 Cr (+19.4% YoY) and net profit of ₹25.2 Cr (+394.1% YoY) for Q4 FY26.
Asston Pharmaceuticals scheduled a board meeting on May 29, 2026, to approve audited FY26 financial results. This routine regulatory notice precedes official performance disclosures.
Ramco Systems reported consolidated annual income of ₹708.20 Crore for FY2026. The Board also approved a new 2026 employee stock option scheme for 15,00,000 shares.
Credo Brands Marketing recommended a final dividend of ₹2 per equity share for FY2026. The record date and payment schedule will be finalized during the upcoming AGM.
Nykaa is acquiring an additional 24.2% stake in Earth Rhythm for ₹9.4 Crore. The deal strengthens Nykaa's sustainable beauty segment and expands its brand portfolio.
Vani Commercials Ltd reported revenue from operations of ₹1.6 Cr and net profit of ₹0.1 Cr (+0.0% YoY) for Q4 FY26.
Aurobindo Pharma reported Q4FY26 revenue of ₹8,853 Cr (+5.6% YoY) and PAT of ₹921 Cr (+2.0% YoY). The firm focuses on biosimilars expansion via CuraTeQ and biologics CDMO through TheraNym.
Vani Commercials Limited approved its FY2026 audited financial results and several acquisitions. The board also authorized a fundraise via preferential equity and CCD issuances.
VA Tech Wabag reported strong FY26 results with a 20% revenue increase and 26% PAT growth, maintaining its net cash-positive status for the 6th consecutive year.
UFO Moviez reported a 161% increase in full-year PAT to ₹24.9 Crore for FY26. Strong theatrical momentum and advertising traction drove robust consolidated revenue growth.
Adani Ports completed the 100% acquisition of Jaypee Fertilizers & Industries Limited from Jaiprakash Associates. The transaction aligns with JAL's approved resolution plan.
Creative Graphics is pivoting from flexographic plates to high-volume pharmaceutical packaging, targeting aggressive expansion but facing significant margin pressure from rising aluminum costs.
Sudeep Pharma reported record FY26 revenue of ₹642.3cr, driven by the listing, the NSS acquisition, and expansion into battery materials.
Rossell India recommended a final dividend of ₹0.40 per share for FY2025-26. August 18 is the record date, with payments due by September 10, 2026.
Niraj Cement Structurals' board approved the re-appointment of Independent Director Partha Sarathi Raut and both internal and cost auditors. These governance renewals ensure management and audit continuity.
Datiware Maritime Infra Limited scheduled a board meeting for May 28, 2026. Directors will consider and approve audited financial results for the 2026 fiscal year.
Link Pharma Chem confirms non-applicability of SEBI's Related Party Transaction disclosure requirements. The company remains below prescribed paid-up capital and net worth thresholds for compliance.
Centrum Capital's Board approved seeking shareholder approval for fund raising through various modes. Specific terms and amounts will be determined by the Board in due course.
Datamatics Global Services re-appointed Rahul Lalit Kanodia as Executive Director for a five-year term. The board also approved re-appointing Ajmera & Ajmera as internal auditors.
LIC recommended a final dividend of ₹10 per equity share for FY 2025-26. The record date is June 25, 2026, with payment scheduled by August 25.